{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:17:22Z","timestamp":1789208242097,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Program on Key Research Project of China","award":["2018YFD0500801"],"award-info":[{"award-number":["2018YFD0500801"]}]},{"name":"National Program on Key Research Project of China","award":["2018YFD0500204"],"award-info":[{"award-number":["2018YFD0500204"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2662016PY003"],"award-info":[{"award-number":["2662016PY003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2662017PY092"],"award-info":[{"award-number":["2662017PY092"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M602324"],"award-info":[{"award-number":["2016M602324"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.10.030","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T09:17:08Z","timestamp":1540286228000},"page":"7353-7360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-\u03b3 as immunoadjuvant in weaning piglets"],"prefix":"10.1016","volume":"36","author":[{"given":"Huawei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.10.030_b0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virusres.2014.12.006","article-title":"Studying classical swine fever virus: making the best of a bad virus","volume":"197","author":"Ji","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.10.030_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v9040086","article-title":"Classical swine fever\u2014an updated review","volume":"9","author":"Blome","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2018.10.030_b0015","first-page":"1","article-title":"An improved indirect ELISA for specific detection of antibodies against classical swine fever virus based on structurally designed E2 protein expressed in suspension mammalian cells","author":"Ji","year":"2018","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vetmic.2017.01.001","article-title":"Classical swine fever vaccines\u2014State-of-the-art","volume":"206","author":"Blome","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0025","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/CVI.00416-14","article-title":"Effectiveness of the E2-classical swine fever virus recombinant vaccine produced and formulated within whey from genetically transformed goats","volume":"21","author":"S\u00e1nchez","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.10.003","article-title":"Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0264-410X(01)00320-6","article-title":"An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus","volume":"20","author":"Dewulf","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0040","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.vaccine.2012.01.051","article-title":"Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission","volume":"30","author":"Lin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2018.04.079","article-title":"Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV","author":"Gao","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0050","doi-asserted-by":"crossref","first-page":"8364","DOI":"10.1016\/j.vaccine.2011.08.085","article-title":"A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever","volume":"29","author":"Sun","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2013.10.025","article-title":"The challenges of classical swine fever control: Modified live and E2 subunit vaccines","volume":"179","author":"Huang","year":"2014","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.10.030_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetmic.2014.04.004","article-title":"Classical swine fever in China: a minireview","volume":"172","author":"Luo","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vetmic.2009.09.043","article-title":"Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs","volume":"142","author":"Tarradas","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0070","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1016\/j.vaccine.2005.01.076","article-title":"Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV","volume":"23","author":"Maurer","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0075","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s10529-017-2426-y","article-title":"Expression and purification of classical swine fever virus E2 protein from Sf9 cells using a modified vector","volume":"39","author":"Yang","year":"2017","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2018.10.030_b0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1865-1682.2012.01327.x","article-title":"Baculovirus expression and antigenic characterization of classical swine fever virus E2 proteins","volume":"60","author":"Luo","year":"2013","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2018.10.030_b0085","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.vaccine.2012.11.013","article-title":"Comprehensive evaluation of the adenovirus\/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever","volume":"31","author":"Sun","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cytogfr.2014.07.015","article-title":"Interferons: success in anti-viral immunotherapy","volume":"25","author":"ching","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2018.10.030_b0095","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.02775-06","article-title":"Enhanced antiviral activity against foot-and-mouth disease virus by a combination of Type I and II porcine interferons","volume":"81","author":"Moraes","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0100","doi-asserted-by":"crossref","unstructured":"Kak G, Raza M, Tiwari BK, Access O. Interferon-gamma (IFN-\u03b3): exploring its implications in infectious diseases IFN-\u03b3: An Introduction; 2018:64\u201379.","DOI":"10.1515\/bmc-2018-0007"},{"key":"10.1016\/j.vaccine.2018.10.030_b0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.vaccine.2012.11.062","article-title":"Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-\u03b3 in mice","volume":"31","author":"Wang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0110","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1016\/j.vaccine.2011.08.118","article-title":"Construction and immunogenicity of recombinant adenovirus expressing ORF2 of PCV2 and porcine IFN gamma","volume":"29","author":"Genmei","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2017.05.019","article-title":"Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFN\u03b3 and GM-CSF in a mouse model of RSV infection","volume":"97","author":"Eichinger","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0120","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1016\/j.vaccine.2012.03.049","article-title":"Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2","volume":"30","author":"Tian","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.030_b0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/vim.2017.0010","article-title":"Effects of vaccination with the C-Strain vaccine on immune cells and cytokines of pigs against classical swine fever virus","volume":"31","author":"Xu","year":"2018","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0378-1135(01)00410-2","article-title":"Classical swine fever (CSF) marker vaccine: Trial II. Challenge study in pregnant sows","volume":"83","author":"Depner","year":"2001","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-1135(01)00409-6","article-title":"Classical swine fever (CSF) marker vaccine - Trial I. challenge studies in weaner pigs","volume":"83","author":"Uttenthal","year":"2001","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1135(99)00003-6","article-title":"Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus","volume":"66","author":"Bouma","year":"1999","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0145","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1089\/jir.2013.0112","article-title":"Type III interferon protects swine against foot-and-mouth disease","volume":"34","author":"Perez-Martin","year":"2014","journal-title":"J Interf Cytokine Res"},{"key":"10.1016\/j.vaccine.2018.10.030_b0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetimm.2011.07.006","article-title":"Immunomodulation of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-\u03b3 and IL-4 genes","volume":"144","author":"Sawant","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2018.10.030_b0155","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1016\/j.vaccine.2010.09.073","article-title":"Human \u03b1IFN co-formulated with milk derived E2-CSFV protein induce early full protection in vaccinated pigs","volume":"28","author":"Toledo","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:58Z","timestamp":1759400938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18313963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":31,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18313963"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-\u03b3 as immunoadjuvant in weaning piglets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}